Placental ischemia-induced increases in brain water content and cerebrovascular permeability: Role of TNF-α

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 11, 2015, Pages R1425-R1431

  Warrington, Junie P ^a   Drummond, Heather A ^a   Granger, Joey P ^a   Ryan, Michael J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

BBB permeability; Cerebrovascular abnormalities; Edema; Preeclampsia; Pregnancy

Indexed keywords

ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN EDEMA; BRAIN WATER; CEREBROVASCULAR PERMEABILITY; FEMALE; HYPERTENSION; ISCHEMIA; MEAN ARTERIAL PRESSURE; NONHUMAN; PERFUSION PRESSURE; PLACENTA DISORDER; PLACENTAL ISCHEMIA; PREGNANCY; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; BODY WATER; BRAIN; CAPILLARY PERMEABILITY; CEREBROVASCULAR DISORDERS; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GESTATIONAL AGE; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PRE-ECLAMPSIA; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; BLOOD PRESSURE; BODY WATER; BRAIN; BRAIN EDEMA; CAPILLARY PERMEABILITY; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; ETANERCEPT; FEMALE; GESTATIONAL AGE; ISCHEMIA; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949256860     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00372.2015     Document Type: Article

References (55)

1. Amburgey OA, Chapman AC, May V, Bernstein IM, Cipolla MJ. Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling. Hypertension 56: 1003–1008, 2010.
2. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122: 1122–1131, 2013.
3. Aygün BK, Baykuş Y, Berilgen S, Kavak B, Celik H, Gurates B. Posterior reversible encephalopathy syndrome in severe preeclampsia: case report and literature review. J Turk Ger Gynecol Assoc 11: 216–219. 2010.
4. Betz AL, Iannotti F, Hoff JT. Brain edema: a classification based on blood-brain barrier integrity. Cerebrovasc Brain Metab Rev 1: 133–154. 1989.
5. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol 36: 635–641, 2009.
6. Chakravarty A, Chakrabarti SD. The neurology of eclampsia : some observations. Neurol India 50: 128–135, 2002.
7. Choi SJ, Lee JE, Oh SY, Kim GM, Cho YS, Lee KH, Kim JH, Roh CR. Maternal cerebral blood flow and glucose metabolism in pregnancies complicated by severe preeclampsia. Hypertens Pregnancy 31: 177–188, 2012.
8. Cipolla MJ, Bishop N, Chan SL. Effect of pregnancy on autoregulation of cerebral blood flow in anterior versus posterior cerebrum. Hypertension 60: 705–711, 2012.
9. Cipolla MJ, Pusic AD, Grinberg YY, Chapman AC, Poynter ME, Kraig RP. Pregnant serum induces neuroinflammation and seizure activity via TNFα. Exp Neurol 234: 398–404, 2012.
10. Demirtaş O, Gelal F, Vidinli BD, Demirtaş LO, Uluç E, Baloğlu A. Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. Diagn Interv Radiol 11: 189–194, 2005.
11. Diav-Citrin O, Otcheretianski-Volodarsky A, Shechtman S, Ornoy A. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. Reprod Toxicol 43: 78–84, 2014.
12. Ekici MA, Uysal O, Cikriklar HI, Özbek Z, Turgut Cosan D, Baydemir C, Kazanci B, Hafizoğlu D. Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury. EurRev Med Pharmacol Sci 18: 10–27, 2014.
13. Fukuda AM, Badaut J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation 9: 279, 2012.
14. Gad HI. The potential role of anti-tumor necrosis factor-alpha antibodies on some renal functions and vasoregulatory factors in preeclamptic pregnant Wistar rats. Saudi Med J 34: 490–496, 2013.
15. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48: 711–716, 2006.
16. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50: 1142–1147, 2007.
17. Gilbert JS, Gilbert SA, Arany M, Granger JP. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53: 399–403, 2009.
18. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122: 383–392, 2006.
19. Gutkowska J, Granger JP, Lamarca BB, Danalache BA, Wang D, Jankowski M. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. J Hy-pertens 29: 1203–1212, 2011.
20. Huang LQ, Zhu GF, Deng YY, Jiang WQ, Fang M, Chen CB, Cao W, Wen MY, Han YL, Zeng HK. Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-α and IL-1β-induced Na-K-Cl Cotransporter up-regulation. J Neuroinflammation 11: 102, 2014.
21. Kalantar F, Rajaei S, Heidari AB, Mansouri R, Rashidi N, Izad MH, Mirahmadian M. Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women. Iran J Nurs Midwifery Res 18: 463–466, 2013.
22. Kim JE, Ryu HJ, Choi SY, Kang TC. Tumor necrosis factor-α-mediated threonine 435 phosphorylation of p65 nuclear factor-κB subunit in endothelial cells induces vasogenic edema and neutrophil infiltration in the rat piriform cortex following status epilepticus. J Neuroinflammation 9: 6, 2012.
23. Kim JE, Ryu HJ, Kang TC. Status epilepticus induces vasogenic edema via tumor necrosis factor-α/endothelin-1-mediated two different pathways. PLoS One 8: e74458, 2013.
24. King MD, Alleyne CH, Dhandapani KM. TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice. Neurosci Lett 542: 92–96, 2013.
25. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52: 1161–1167, 2008.
26. LaMarca B, Wallace K, Granger J. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Curr Opin Pharmacol 11: 175–179, 2011.
27. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022–1025, 2005.
28. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 46: 82–86, 2005.
29. Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, Jordan V, Chamley LW. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and metaanalysis. Am J Reprod Immunol 70: 412–427, 2013.
30. Lei B, Dawson HN, Roulhac-Wilson B, Wang H, Laskowitz DT, James ML. Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation 10: 103, 2013.
31. Lv S, Song HL, Zhou Y, Li LX, Cui W, Wang W, Liu P. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure. Liver Int 30: 1198–1210, 2010.
32. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97: 533–538, 2001.
33. Mitas L, Rogulski L. Acute cortical blindness in preeclampsia—a case of reversible posterior encephalopathy syndrome. Ginekol Pol 83: 469–472, 2012.
34. Mohajertehran F, Tavakkol Afshari J, Rezaieyazdi Z, Ghomian N. Association of single nucleotide polymorphisms in the human tumor necrosis factor-α and interleukin 1-β genes in patients with pre-eclampsia. Iran J Allergy Asthma Immunol 11: 224–229, 2012.
35. Naderi M, Yaghootkar H, Tara F, Tavakkol Afshari J, Farid Hosseini R, Ghayour Mobarhan M, Shapouri Moghadam A, Mirteimouri M, Tara SM. Tumor necrosis factor-alpha polymorphism at position —238 in preeclampsia. Iran Red Crescent Med J 16: e11195, 2014.
36. Nicchia GP, Nico B, Camassa LM, Mola MG, Loh N, Dermietzel R, Spray DC, Svelto M, Frigeri A. The role of aquaporin-4 in the blood-brain barrier development and integrity: studies in animal and cell culture models. Neuroscience 129: 935–945, 2004.
37. Riskin-Mashiah S, Belfort MA. Preeclampsia is associated with global cerebral hemodynamic changes. J Soc Gynecol Investig 12: 253–256, 2005.
38. Ryan MJ, Gilbert EL, Glover PH, George EM, Masterson CW, McLemore GR, LaMarca B, Granger JP, Drummond HA. Placental ischemia impairs middle cerebral artery myogenic responses in the pregnant rat. Hypertension 58: 1126–1131, 2011.
39. Schreurs MP, Cipolla MJ. Cerebrovascular dysfunction and blood-brain barrier permeability induced by oxidized LDL are prevented by apocynin and magnesium sulfate in female rats. J Cardiovasc Pharmacol 2013.
40. Schreurs MP, Hubel CA, Bernstein IM, Jeyabalan A, Cipolla MJ. Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. FASEB J 27: 1254–1263, 2013.
41. Scioscia C, Scioscia M, Anelli MG, Praino E, Bettocchi S, Lapadula G. Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis. Clin Exp Rheumatol 29: 93–95, 2011.
42. Sunderland NS, Thomson SE, Heffernan SJ, Lim S, Thompson J, Ogle R, McKenzie P, Kirwan PJ, Makris A, Hennessy A. Tumor necrosis factor a induces a model of preeclampsia in pregnant baboons (Papio hamadryas). Cytokine 56: 192–199, 2011.
43. Taki A, Abe M, Komaki M, Oku K, Iseki S, Mizutani S, Morita I. Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 52: 97–103, 2012.
44. Tang CH, Wu CS, Lee TH, Hung ST, Yang CY, Lee CH, Chu PH. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke 40: 1162–1168, 2009.
45. Topuz S, Kalelioğlu I, Iyibozkurt AC, Akhan S, Has R, Tunaci M, Ibrahimoğlu L. Cranial imaging spectrum in hypertensive disease of pregnancy. Clin Exp Obstet Gynecol 35: 194–197, 2008.
46. Tsuge M, Yasui K, Ichiyawa T, Saito Y, Nagaoka Y, Yashiro M, Yamashita N, Morishima T. Increase of tumor necrosis factor-alpha in the blood induces early activation of matrix metalloproteinase-9 in the brain. Microbiol Immunol 54: 417–424, 2010.
47. Umeda N, Ito S, Hayashi T, Goto D, Matsumoto I, Sumida T. A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment. Intern Med 49: 187–189, 2010.
48. Viktil KK, Engeland A, Furu K. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J Rheumatol 41: 196–201, 2012.
49. Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17: 641–649, 2010.
50. Wang W, Lv S, Zhou Y, Fu J, Li C, Liu P. Tumor necrosis factor-a affects blood-brain barrier permeability in acetaminophen-induced acute liver failure. Eur J Gastroenterol Hepatol 23: 552–558, 2011.
51. Warrington JP, Fan F, Murphy SR, Roman RJ, Drummond HA, Granger JP, Ryan MJ. Placental ischemia in pregnant rats impairs cerebral blood flow autoregulation and increases blood-brain barrier permeability. Physiol Rep 2: 2014.
52. Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, Beghin D, Cuppers-Maarschalkerweerd B, Richardson JL, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadioglu Duman M, Meister R, Schaefer C. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol 2015.
53. Wiegman MJ, Zeeman GG, Aukes AM, Bolte AC, Faas MM, Aarnoudse JG, de Groot JC. Regional distribution of cerebral white matter lesions years after preeclampsia and eclampsia. Obstet Gynecol 123: 790–795, 2014.
54. Youssef AM, Hamidian Jahromi A, Vijay CG, Granger DN, Alexander JS. Intra-abdominal hypertension causes reversible blood-brain barrier disruption. J Trauma Acute Care Surg 72: 183–188, 2012.
55. Zhou P, Luo X, Qi HB, Zong WJ, Zhang H, Liu DD, Li QS. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res 61: 1005–1012, 2012.